Similar Posts
The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost
The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost Thu, 28 Apr 2005 What does $4 billion dollars in drug advertising buy? The Washington Post reports that a University of Washington study published in the Journal of the American Medical Association confirms the insidious…
FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing
Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.
Biederman J & J Risperdal Documents
A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing division-provide a bird’s eye view of collusion between the drug giant and Harvard’s leading child psychiatrist, Dr. Joseph Biederman, and one of Harvard’s premier teaching hospitals, Massachusetts General Hospital.
DHHS Reverses its Legal Position Petitioning FOR Whistleblower Protection for Dr. Fishbein
DHHS Reverses its Legal Position Petitioning FOR Federal Whistleblower Protection for Dr. Fishbein Thu, 3 Feb 2005 The Washington Post reports: “Department of Health and Human Services filed a legal petition this week in support of an employee the department is trying to fire. HHS told the Merit Systems Protection…
An Open Letter to Officials of the National Institute of Mental Health
An Open Letter to Officials of the National Institute of Mental Health Fri, 30 Apr 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting openness and full disclosure https://ahrp.org From: Vera Hassner Sharav, President David Cohen, Ph.D. Secretary The ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) To: Thomas Insell, MD,…
Medicaid Battles: Law firm With Ties to Drug Makers Joins Fight in Tennessee / NYT Blind Spot
Medicaid Battles: Law firm With Ties to Drug Makers Joins Fight in Tennessee / NYT Blind Spot Mon, 14 Mar 2005 The Tennessean reports: “An international law firm with ties to major drug manufacturers is providing free legal help to the advocacy group seeking to block the state from cutting…